Literature DB >> 24878135

Dabigatran in catheter ablation of atrial fibrillation: a call for a randomized control trial.

Aref A Bin Abdulhak1, Abdur Rahman Khan2, Alan P Wimmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24878135     DOI： 10.1016/j.amjcard.2014.03.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  1 in total

1.  Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Authors:  Riccardo Cappato; Francis E Marchlinski; Stefan H Hohnloser; Gerald V Naccarelli; Jim Xiang; David J Wilber; Chang-Sheng Ma; Susanne Hess; Darryl S Wells; George Juang; Johan Vijgen; Burkhard J Hügl; Richard Balasubramaniam; Christian De Chillou; D Wyn Davies; L Eugene Fields; Andrea Natale
Journal:  Eur Heart J       Date:  2015-05-14       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.